{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05734196",
            "orgStudyIdInfo": {
                "id": "INZ701-104"
            },
            "organization": {
                "fullName": "Inozyme Pharma",
                "class": "INDUSTRY"
            },
            "briefTitle": "The ENERGY Study: Evaluation of Safety and Tolerability of INZ-701 in Infants With ENPP1 Deficiency or ABCC6 Deficiency",
            "officialTitle": "The ENERGY Study: An Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INZ-701 in Infants With Ectonucleotide Pyrophosphatase/ Phosphodiesterase 1 (ENPP1) Deficiency or ATP-binding Cassette Sub-family C Member 6 (ABCC6) Deficiency",
            "acronym": "ENERGY",
            "therapeuticArea": [
                "Critical Care",
                "Other"
            ],
            "study": "the-energy-study-evaluation-of-safety-and-tolerability-of-inz-in-infants-with-deficiency-or-deficiency"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-06-25",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-03-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-04-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-01-26",
            "studyFirstSubmitQcDate": "2023-02-15",
            "studyFirstPostDateStruct": {
                "date": "2023-02-17",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-17",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-20",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Inozyme Pharma",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The primary purpose of Study INZ701-104 (the ENERGY study) is to assess the safety and tolerability of INZ-701 in infants with ENPP1 Deficiency or with ABCC6 Deficiency.",
            "detailedDescription": "INZ-701 is an ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) enzyme replacement therapy in development for the treatment of the ultra-rare genetic disorder, ENPP1 Deficiency or with ABCC6 Deficiency.\n\nStudy INZ701-104 (the ENERGY study) is a Phase 1b, open-label study to assess the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of INZ-701 in infant study participants with ENPP1 Deficiency or ABCC6 Deficiency.\n\nThe study will consist of up to a 60-day Screening Period, a 52-week Treatment Period during which study participants will receive INZ-701, an Extension Period during which participants may continue to receive INZ-701 until it is commercially available in the country where the participant resides, or until an alternative study of INZ-701 is available, and an End of Treatment (EOT) visit 30 days after the last dose of INZ-701. Upon treatment discontinuation, participants will continue to be followed for their ongoing disposition for survival outcome at least quarterly through the end of the study."
        },
        "conditionsModule": {
            "conditions": [
                "Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency",
                "Autosomal Recessive Hypophosphatemic Rickets",
                "Generalized Arterial Calcification of Infancy",
                "ATP-Binding Cassette Subfamily C Member 6 Deficiency",
                "Pseudoxanthoma Elasticum"
            ],
            "keywords": [
                "ectonucleotide pyrophosphatase/phosphodiesterase1 deficiency",
                "hypopyrophosphatemia",
                "ENPP1",
                "Generalized Arterial Calcification of Infancy",
                "GACI",
                "Autosomal Recessive Hypophosphatemic Rickets Type 2",
                "ARHR2",
                "ATP-Binding Cassette Subfamily C Member 6 Deficiency",
                "ABCC6",
                "Pseudoxanthoma elasticum",
                "PXE"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "interventionModelDescription": "Study INZ701-104 is a Phase 1b, open-label study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of INZ-701 in infant study participants with ENPP1 Deficiency or with ABCC6 Deficiency.",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 16,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "INZ-701",
                    "type": "EXPERIMENTAL",
                    "description": "The first 2 study participants will receive 1 dose of 0.2 mg/kg on Day 1 and start at Dose Level A (0.2 mg/kg twice weekly) on Day 8.\n\nThe Data Review Committee (DRC) comprised of representatives of the Sponsor, the study Investigators, and a physician who is a subject matter expert not affiliated with the study or Sponsor, will review the safety data of the first study participant through Day 8. Contingent upon this review, the Sponsor will decide if additional study participants can begin receiving INZ-701.\n\nAfter the second study participant completes Day 32, the DRC will perform a cumulative review of safety and PK/PD data and will make dosing recommendations, for example, modifying the dose of the ongoing study participants and/or changing the starting dose for future participants.\n\nDose Level A: 0.2 mg/kg twice weekly\n\nDose Level B: 0.6 mg/kg twice weekly\n\nDose Level C: 0.2 mg/kg once weekly\n\nDose Level D: 0.6 mg/kg once weekly\n\nDose Level E: 1.8 mg/kg once weekly",
                    "interventionNames": [
                        "Drug: INZ-701"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "INZ-701",
                    "description": "Recombinant fusion protein that contains the extracellular domains of human ENPP1 coupled with an Fc fragment from an immunoglobulin gamma-1 (IgG1) antibody.",
                    "armGroupLabels": [
                        "INZ-701"
                    ],
                    "otherNames": [
                        "(rhENPP1-Fc)."
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Number of Treatment Emergent Adverse Events (TEAEs)",
                    "description": "Treatment-emergent AEs are defined as any AE occurring from the first dose of INZ-701 through 30 days after the last dose of INZ-701.",
                    "timeFrame": "52 weeks (Treatment Period)"
                },
                {
                    "measure": "Incidence of Anti-Drug Antibodies (ADA)",
                    "description": "For each participant, the presence of ADAs will be assessed and, if present, further evaluation will determine specificity and subtypes.",
                    "timeFrame": "52 weeks (Treatment Period)"
                },
                {
                    "measure": "Left Ventricular Ejection Fraction",
                    "description": "For each participant, an echocardiogram will be collected, and used to assess heart function. (Including measurement of left ventricular ejection fraction), and to identify any other abnormalities, for example, calcification of heart valves.",
                    "timeFrame": "52 weeks (Treatment Period)"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change from Baseline in Plasma Inorganic Pyrophosphate (PPi) Levels",
                    "description": "For each participant, plasma PPi will be measured via a series of blood samples obtained throughout the study, comparing the participant's baseline value over time.",
                    "timeFrame": "52 weeks (Treatment Period)"
                },
                {
                    "measure": "Area under the Plasma Concentration versus Time Curve (AUC) of INZ-701",
                    "description": "For each participant, variation of concentration of INZ-701 in the plasma will be measured via a series of blood samples obtained throughout the study, comparing the participant's baseline value over time.",
                    "timeFrame": "52 weeks (Treatment Period)"
                },
                {
                    "measure": "Maximum Plasma Concentration (Cmax) of INZ-701",
                    "description": "For each participant, the maximum concentration of INZ-701 in the plasma will be measured via a series of blood samples obtained throughout the study, comparing the participant's baseline value over time.",
                    "timeFrame": "52 weeks (Treatment Period)"
                },
                {
                    "measure": "ENPP1 Activity",
                    "description": "For each participant, the activity of INZ-701 in the serum will be measured via a series of blood samples obtained throughout the study, comparing the participant's baseline value over time.",
                    "timeFrame": "52 weeks (Treatment Period)"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Caregiver(s) must provide written or electronic consent after the nature of the study has been explained, and prior to any research-related procedures, per International Council for Harmonisation (ICH) Good Clinical Practice (GCP)\n2. Study participant must have a confirmed post-natal molecular genetic diagnosis of ENPP1 Deficiency or ABCC6 Deficiency with biallelic mutations (ie, homozygous or compound heterozygous) performed by a College of American Pathologists/Clinical Laboratory Improvement Amendments (CAP/CLIA) certified laboratory\n3. Study participants must have clinical manifestations of GACI or GACI-2, which may include, but are not limited to, pathologic ectopic calcification, heart failure, respiratory distress, edema, cyanosis, hypertension, and cardiomegaly\n4. Study participant must be male or female from birth to \\<1 year of age at Baseline (Day 1)\n5. Study participant must weigh \u22650.5 kg at the time of the first dose of INZ-701 in this study\n6. In the opinion of the Investigator, the study participant must be able to complete all aspects of the study\n7. Study participant's caregiver(s) must agree to provide access to their child's relevant medical records\n\nExclusion Criteria:\n\n1. In the opinion of the Investigator, presence of any clinically significant disease or laboratory abnormality (outside of those considered associated with the diagnosis of ENPP1 Deficiency or ABCC6 Deficiency) that precludes study participation or may confound interpretation of study results, including known uncontrolled thyroid disease or unrelated connective tissue, bone, mineral, or muscle disease\n2. Care has been withdrawn or study participant is receiving end of life care or hospice only\n3. Known malignancy\n4. Known intolerance to INZ-701 or any of its excipients\n5. Concurrent participation in another non-Inozyme interventional study\n6. Receipt of any non-Inozyme investigational new drug within 5 half-lives of the last dose of the other investigational product or within 4 weeks prior to the first dose of INZ-701, whichever is longer, or use of an investigational device, through completion of participation in the study",
            "healthyVolunteers": false,
            "sex": "ALL",
            "maximumAge": "1 Year",
            "stdAges": [
                "CHILD"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Inozyme Clinical Trial Information",
                    "role": "CONTACT",
                    "phone": "+1 857 330 4340",
                    "email": "clinicaltrials@inozyme.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Alex Lai, MD",
                    "affiliation": "Inozyme Pharma",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Rady Children's Hospital",
                    "status": "RECRUITING",
                    "city": "San Diego",
                    "state": "California",
                    "zip": "92123",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Nathaly Sweeney, MD",
                            "role": "CONTACT",
                            "phone": "858-966-5818",
                            "email": "nsweeney@rchsd.org"
                        },
                        {
                            "name": "Sarah Lazar, MPH",
                            "role": "CONTACT",
                            "phone": "8585761700",
                            "email": "slazar@health.ucsd.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.71533,
                        "lon": -117.15726
                    }
                },
                {
                    "facility": "Boston Children's Hospital",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02115",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Alayna Dutcher",
                            "role": "CONTACT",
                            "phone": "617-355-0741",
                            "email": "Alayna.dutcher@childrens.harvard.edu"
                        },
                        {
                            "name": "Andrea Hale, RN, MPH",
                            "role": "CONTACT",
                            "phone": "617-919-2867",
                            "email": "andrea.hale@childrens.harvard.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "Nationwide Children's Hospital",
                    "status": "RECRUITING",
                    "city": "Columbus",
                    "state": "Ohio",
                    "zip": "43205",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Bimal Chaudhari, MD",
                            "role": "CONTACT",
                            "phone": "614-722-3535",
                            "email": "bimal.chaudhari@nationwidechildrens.org"
                        },
                        {
                            "name": "Marina Artemova, PhD",
                            "role": "CONTACT",
                            "phone": "614-722-2655",
                            "email": "marina.artemova@nationwidechildrens.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.96118,
                        "lon": -82.99879
                    }
                },
                {
                    "facility": "The Children's Hospital of Philadelphia",
                    "status": "RECRUITING",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19104",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Maximilian Krumpholz",
                            "role": "CONTACT",
                            "phone": "267-432-0511",
                            "email": "krumpholm1@chop.edu"
                        },
                        {
                            "name": "Rachel Walega",
                            "role": "CONTACT",
                            "phone": "267-586-5969",
                            "email": "WALEGAR1@chop.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                },
                {
                    "facility": "The University of Utah",
                    "status": "RECRUITING",
                    "city": "Salt Lake City",
                    "state": "Utah",
                    "zip": "84108",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Carrie Bailey, BS",
                            "role": "CONTACT",
                            "phone": "801-587-3605",
                            "email": "ped_mgr@lists.hsc.utah.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.76078,
                        "lon": -111.89105
                    }
                },
                {
                    "facility": "Hospital Sant Joan de D\u00e9u",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Barcelona",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Georgia Sarquella-Brugada, MD",
                            "role": "CONTACT",
                            "email": "georgia.sarquella@sjd.es"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "Royal Manchester Children's Hospital",
                    "status": "RECRUITING",
                    "city": "Manchester",
                    "zip": "M13 9WL",
                    "country": "United Kingdom",
                    "contacts": [
                        {
                            "name": "Amish Chinoy, MD",
                            "role": "CONTACT",
                            "phone": "0161 701 7901",
                            "email": "amish.chinoy@mft.nhs.uk"
                        },
                        {
                            "name": "Victoria Hamilton, RN",
                            "role": "CONTACT",
                            "phone": "0161 701 8313",
                            "email": "victoria.hamilton@mft.nhs.uk"
                        }
                    ],
                    "geoPoint": {
                        "lat": 53.48095,
                        "lon": -2.23743
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000012279",
                    "term": "Rickets"
                },
                {
                    "id": "D000063730",
                    "term": "Rickets, Hypophosphatemic"
                },
                {
                    "id": "D000053098",
                    "term": "Familial Hypophosphatemic Rickets"
                },
                {
                    "id": "D000011561",
                    "term": "Pseudoxanthoma Elasticum"
                },
                {
                    "id": "D000002114",
                    "term": "Calcinosis"
                }
            ],
            "ancestors": [
                {
                    "id": "D000002128",
                    "term": "Calcium Metabolism Disorders"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                },
                {
                    "id": "D000001851",
                    "term": "Bone Diseases, Metabolic"
                },
                {
                    "id": "D000001847",
                    "term": "Bone Diseases"
                },
                {
                    "id": "D000009140",
                    "term": "Musculoskeletal Diseases"
                },
                {
                    "id": "D000014808",
                    "term": "Vitamin D Deficiency"
                },
                {
                    "id": "D000001361",
                    "term": "Avitaminosis"
                },
                {
                    "id": "D000003677",
                    "term": "Deficiency Diseases"
                },
                {
                    "id": "D000044342",
                    "term": "Malnutrition"
                },
                {
                    "id": "D000009748",
                    "term": "Nutrition Disorders"
                },
                {
                    "id": "D000017674",
                    "term": "Hypophosphatemia"
                },
                {
                    "id": "D000010760",
                    "term": "Phosphorus Metabolism Disorders"
                },
                {
                    "id": "D000007015",
                    "term": "Hypophosphatemia, Familial"
                },
                {
                    "id": "D000015499",
                    "term": "Renal Tubular Transport, Inborn Errors"
                },
                {
                    "id": "D000007674",
                    "term": "Kidney Diseases"
                },
                {
                    "id": "D000014570",
                    "term": "Urologic Diseases"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000052801",
                    "term": "Male Urogenital Diseases"
                },
                {
                    "id": "D000008664",
                    "term": "Metal Metabolism, Inborn Errors"
                },
                {
                    "id": "D000008661",
                    "term": "Metabolism, Inborn Errors"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                },
                {
                    "id": "D000020141",
                    "term": "Hemostatic Disorders"
                },
                {
                    "id": "D000014652",
                    "term": "Vascular Diseases"
                },
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                },
                {
                    "id": "D000006474",
                    "term": "Hemorrhagic Disorders"
                },
                {
                    "id": "D000006402",
                    "term": "Hematologic Diseases"
                },
                {
                    "id": "D000012868",
                    "term": "Skin Abnormalities"
                },
                {
                    "id": "D000000013",
                    "term": "Congenital Abnormalities"
                },
                {
                    "id": "D000012873",
                    "term": "Skin Diseases, Genetic"
                },
                {
                    "id": "D000003240",
                    "term": "Connective Tissue Diseases"
                },
                {
                    "id": "D000012871",
                    "term": "Skin Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M27133",
                    "name": "Familial Hypophosphatemic Rickets",
                    "asFound": "Hypophosphatemic Rickets",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5377",
                    "name": "Calcinosis",
                    "asFound": "Calcification",
                    "relevance": "HIGH"
                },
                {
                    "id": "M15108",
                    "name": "Rickets",
                    "asFound": "Rickets",
                    "relevance": "HIGH"
                },
                {
                    "id": "M30150",
                    "name": "Rickets, Hypophosphatemic",
                    "asFound": "Hypophosphatemic Rickets",
                    "relevance": "HIGH"
                },
                {
                    "id": "M14418",
                    "name": "Pseudoxanthoma Elasticum",
                    "asFound": "Pseudoxanthoma Elasticum",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5391",
                    "name": "Calcium Metabolism Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M5130",
                    "name": "Bone Diseases, Metabolic",
                    "relevance": "LOW"
                },
                {
                    "id": "M5126",
                    "name": "Bone Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12097",
                    "name": "Musculoskeletal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17551",
                    "name": "Vitamin D Deficiency",
                    "relevance": "LOW"
                },
                {
                    "id": "M4660",
                    "name": "Avitaminosis",
                    "relevance": "LOW"
                },
                {
                    "id": "M6879",
                    "name": "Deficiency Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M25306",
                    "name": "Malnutrition",
                    "relevance": "LOW"
                },
                {
                    "id": "M12684",
                    "name": "Nutrition Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M19894",
                    "name": "Hypophosphatemia",
                    "relevance": "LOW"
                },
                {
                    "id": "M13660",
                    "name": "Phosphorus Metabolism Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M10065",
                    "name": "Hypophosphatemia, Familial",
                    "relevance": "LOW"
                },
                {
                    "id": "M18151",
                    "name": "Renal Tubular Transport, Inborn Errors",
                    "relevance": "LOW"
                },
                {
                    "id": "M10698",
                    "name": "Kidney Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17319",
                    "name": "Urologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M27095",
                    "name": "Male Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M11641",
                    "name": "Metabolism, Inborn Errors",
                    "relevance": "LOW"
                },
                {
                    "id": "M11644",
                    "name": "Metal Metabolism, Inborn Errors",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "M21977",
                    "name": "Hemostatic Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M5059",
                    "name": "Blood Coagulation Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M17400",
                    "name": "Vascular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M9560",
                    "name": "Hemorrhagic Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M9490",
                    "name": "Hematologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12",
                    "name": "Congenital Abnormalities",
                    "relevance": "LOW"
                },
                {
                    "id": "M15672",
                    "name": "Skin Abnormalities",
                    "relevance": "LOW"
                },
                {
                    "id": "M15674",
                    "name": "Skin Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M15676",
                    "name": "Skin Diseases, Genetic",
                    "relevance": "LOW"
                },
                {
                    "id": "M6464",
                    "name": "Connective Tissue Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T5019",
                    "name": "Rickets",
                    "asFound": "Rickets",
                    "relevance": "HIGH"
                },
                {
                    "id": "T2954",
                    "name": "Hypophosphatemic Rickets",
                    "asFound": "Hypophosphatemic Rickets",
                    "relevance": "HIGH"
                },
                {
                    "id": "T4798",
                    "name": "Pseudoxanthoma Elasticum",
                    "asFound": "Pseudoxanthoma Elasticum",
                    "relevance": "HIGH"
                },
                {
                    "id": "T486",
                    "name": "Arterial Calcification of Infancy",
                    "asFound": "Arterial Calcification of Infancy",
                    "relevance": "HIGH"
                },
                {
                    "id": "T5976",
                    "name": "X-linked Hypophosphatemia",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC05",
                    "name": "Musculoskeletal Diseases"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "BC15",
                    "name": "Blood and Lymph Conditions"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M4225",
                    "name": "Antibodies",
                    "relevance": "LOW"
                },
                {
                    "id": "M10184",
                    "name": "Immunoglobulins",
                    "relevance": "LOW"
                },
                {
                    "id": "M19117",
                    "name": "Immunoglobulins, Intravenous",
                    "relevance": "LOW"
                },
                {
                    "id": "M10189",
                    "name": "Immunoglobulin Fc Fragments",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}